Allahabad HC: Victim Compensation under POCSO Act Cannot be Withheld For Lack of Injury Report  ||  MP HC: Diverting Goods From Delivery Point is Misappropriation under S.407 IPC  ||  Delhi HC: Bar Associations are Not ‘State’ under Article 12 as They Do Not Perform Public Functions  ||  Delhi HC: Pending Probate Proceedings Do Not Prevent Filing FIR For Alleged Will Forgery  ||  Ker HC: Dismissal For Default Alone Cannot Justify Rejecting Restoration Plea For Lack of Vigilance  ||  SC: Disclosure Statements Alone Cannot Secure Conviction Without a Complete Chain of Evidence  ||  Supreme Court Orders Reporting of Student Suicides and Bans Denial of Classes or Exams  ||  SC: Govt Can Exclude Overqualified Candidates From Posts Requiring Lower Qualifications  ||  SC: Contracts to Hire Global Speakers For Media Summits are Not Taxable as Event Management Services  ||  SC: Mandatory Injunction Suit Alone is Not Maintainable When Plaintiff’s Title is Disputed    

SEBI Imposes Rs. 22 Crore fine on Aurobindo Pharma for Insider Trading - (24 Sep 2019)

CAPITAL MARKET

Securities and Exchange Board of India has imposed a fine of Rs. 22.7 crore on Aurobindo Pharma Ltd., its promoters and related entities for insider trading between July, 2008 to March, 2009.

Tags : SECURITIES AND EXCHANGE BOARD OF INDIA   AUROBINDO PHARMA LTD.  SEBI  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved